These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulation of pituitary ACTH secretion during chronic stress. Aguilera G. Front Neuroendocrinol; 1994 Dec; 15(4):321-50. PubMed ID: 7895891 [Abstract] [Full Text] [Related]
23. Increased vasopressinergic activity as a possible compensatory mechanism for a normal hypothalamic-pituitary-adrenal axis response to stress in BALB/c nude mice. Spinedi E, Hadid R, Gaillard RC. Neuroendocrinology; 1997 Oct; 66(4):287-93. PubMed ID: 9349663 [Abstract] [Full Text] [Related]
24. Gestational hypoxia alone or combined with restraint sensitizes the hypothalamic-pituitary-adrenal axis and induces anxiety-like behavior in adult male rat offspring. Fan JM, Chen XQ, Jin H, Du JZ. Neuroscience; 2009 Apr 10; 159(4):1363-73. PubMed ID: 19409200 [Abstract] [Full Text] [Related]
25. The effect of insulin-induced hypoglycemia on gene expression in the hypothalamic-pituitary-adrenal axis of the rat. Robinson BG, Mealy K, Wilmore DW, Majzoub JA. Endocrinology; 1992 Feb 10; 130(2):920-5. PubMed ID: 1310284 [Abstract] [Full Text] [Related]
26. Glucocorticoid Fast Feedback Inhibition of Stress-Induced ACTH Secretion in the Male Rat: Rate Independence and Stress-State Resistance. Osterlund CD, Rodriguez-Santiago M, Woodruff ER, Newsom RJ, Chadayammuri AP, Spencer RL. Endocrinology; 2016 Jul 10; 157(7):2785-98. PubMed ID: 27145013 [Abstract] [Full Text] [Related]
27. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Kumari M, Cover PO, Poyser RH, Buckingham JC. Br J Pharmacol; 1997 Jun 10; 121(3):459-68. PubMed ID: 9179387 [Abstract] [Full Text] [Related]
28. Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release. Konakchieva R, Mitev Y, Almeida OF, Patchev VK. Biol Cell; 1997 Dec 10; 89(9):587-96. PubMed ID: 9673011 [Abstract] [Full Text] [Related]
29. Neonatal facilitation of stress-induced adrenocorticotropin secretion by prior stress: evidence for increased central drive to the pituitary. Walker CD, Dallman MF. Endocrinology; 1993 Mar 10; 132(3):1101-7. PubMed ID: 8382596 [Abstract] [Full Text] [Related]
30. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Seal LJ, Small CJ, Dhillo WS, Kennedy AR, Ghatei MA, Bloom SR. Neuroendocrinology; 2002 Aug 10; 76(2):70-8. PubMed ID: 12169768 [Abstract] [Full Text] [Related]
31. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline. Hadley AJ, Kumari M, Cover PO, Osborne J, Poyser R, Flack JD, Buckingham JC. Br J Pharmacol; 1996 Oct 10; 119(3):463-70. PubMed ID: 8894165 [Abstract] [Full Text] [Related]
32. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone. Kamilaris TC, Johnson EO, Calogero AE, Kalogeras KT, Bernardini R, Chrousos GP, Gold PW. Endocrinology; 1992 Apr 10; 130(4):1764-74. PubMed ID: 1312423 [Abstract] [Full Text] [Related]
33. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone. Akana SF, Scribner KA, Bradbury MJ, Strack AM, Walker CD, Dallman MF. Endocrinology; 1992 Aug 10; 131(2):585-94. PubMed ID: 1322275 [Abstract] [Full Text] [Related]
34. Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats. Widmaier EP, Rosen K, Abbott B. Endocrinology; 1992 Nov 10; 131(5):2313-8. PubMed ID: 1330498 [Abstract] [Full Text] [Related]
35. Dexamethasone and stressor-magnitude regulation of stress-induced transcription of HPA axis secretagogues in the rat. Helmreich DL, Parfitt DB, Walton JR, Richards LM. Stress; 2008 Jul 10; 11(4):302-11. PubMed ID: 18574790 [Abstract] [Full Text] [Related]
36. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Bornstein SR, Webster EL, Torpy DJ, Richman SJ, Mitsiades N, Igel M, Lewis DB, Rice KC, Joost HG, Tsokos M, Chrousos GP. Endocrinology; 1998 Apr 10; 139(4):1546-55. PubMed ID: 9528933 [Abstract] [Full Text] [Related]
37. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. Ochedalski T, Subburaju S, Wynn PC, Aguilera G. J Neuroendocrinol; 2007 Mar 10; 19(3):189-97. PubMed ID: 17280592 [Abstract] [Full Text] [Related]
38. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW. J Clin Endocrinol Metab; 1991 Dec 10; 73(6):1224-34. PubMed ID: 1659582 [Abstract] [Full Text] [Related]
39. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Endocrinology; 1991 Jan 10; 128(1):37-44. PubMed ID: 1846105 [Abstract] [Full Text] [Related]
40. Evidence suggesting that ghrelin O-acyl transferase inhibitor acts at the hypothalamus to inhibit hypothalamo-pituitary-adrenocortical axis function in the rat. Rucinski M, Ziolkowska A, Szyszka M, Hochol A, Malendowicz LK. Peptides; 2012 Jun 10; 35(2):149-59. PubMed ID: 22543218 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]